A5011027690- Veterinary Oncology Research
- Virus-based gene therapy research
- Microbial infections and disease research
- Microbial Inactivation Methods
- Occupational and environmental lung diseases
- Veterinary Orthopedics and Neurology
- Oral and Maxillofacial Pathology
- Infectious Diseases and Mycology
- Medical Imaging and Pathology Studies
Université Claude Bernard Lyon 1
2021-2024
VetAgro Sup
2021-2024
Abstract Specific data regarding outcome of cats with high‐grade and large granular lymphocyte alimentary lymphoma (HGAL LGL, respectively) treated multi‐agent chemotherapy are scarce. The aims this multi‐centric, retrospective study were to describe the HGAL LGL COP‐ or CHOP‐based identify potential prognostic factors. Cats a cytological histological diagnosis protocol as first‐line included. Data diagnosis, staging, treatment follow‐up collected. Fifty‐seven CHOP ( n = 37) COP 20)...
Overall prevalence of severe adverse events (sAE) has been poorly studied in veterinary medicine and peer-reviewed studies mostly focused on a single protocol, making it difficult to have general overview. The aim this retrospective study was assess the frequency risk factors sAE secondary various protocols chemotherapy dogs. Medical records 155 dogs receiving between January 2013 December 2018 were reviewed. Adverse (AE) graded according Veterinary Comparative Oncology Group-common...
ABSTRACT Electrochemotherapy (ECT) with intravenous (IV) and/or intratumoral (IT) bleomycin has shown considerable efficacy in the treatment of non‐resectable feline cutaneous squamous cell carcinoma (cSCC), boasting response rates up to 95%, but other chemotherapy protocols have not yet been investigated. The objective this prospective multicentre study was compare overall rate (ORR) and progression‐free interval (PFI) between cats cSCC treated ECT using IT IV carboplatin (IV + IT), or...